Delivery Order SPE2DB20D3103-SPE2DB25FQ4R1
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,557.76 to AmerisourceBergen Drug Corp for the supply of Leucovorin Calcium 500 mg vials. This non-set-aside, firm fixed-price delivery order was awarded on June 5, 2025, with an ultimate completion date of June 6, 2025. The contractor will perform the work at its Corporate Office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Leucovorin Calcium 500 mg vials under a firm fixed-price contract valued at $3,031.20. The award was issued on August 21, 2025, with an ultimate completion date of August 22, 2025, and represents a non-set-aside competitive award. AmerisourceBergen will perform this contract from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Leucovorin Calcium 500 mg vials, with an award value of $3,235.10. The contract is structured as a firm fixed price delivery order with no set-aside designation, indicating competitive award to this established pharmaceutical vendor. The ultimate completion date is September 17, 2025, just one day following the September 16, 2025 award date. Performance will be...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,600.50 to AmerisourceBergen Drug Corp for the supply of Leucovorin Calcium 500 mg/50 mL vials on September 4, 2025, with completion scheduled for September 5, 2025. This firm fixed-price delivery order carries no set-aside designation and represents a competitively awarded procurement. The product will be delivered to the company's location in Conshohocken, Pennsylvania. This award is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,823.16 to AmerisourceBergen Drug Corp for Leucovorin Calcium 25 mg tablets (25-count packaging). This is a firm fixed price, competitively awarded contract with no set-aside designation, completed on May 20, 2025. The work is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Leucovorin Calcium 5 mg tablets (100-count) under a firm fixed price contract valued at $2,351.52. The award was made on April 24, 2025, with an ultimate completion date of April 25, 2025. This competitively awarded, non-set-aside delivery order represents a routine pharmaceutical procurement to support federal medical supply chain requirements. The contract will be performed at...
- The Defense Logistics Agency awarded a $61,880 delivery order to Amerisourcebergen Drug Corporation for 4561888097 LEUCOVORIN CAL 500 MG/50 ML VL 50ML. The firm fixed price order is being fulfilled under DLA's Prime Vendor Program and calls for the delivery of Leucovorin calcium injection to a Defense Department facility located in Conshohocken, Pennsylvania. Performance will take place from August 21-22, 2023. As a leading healthcare services company, Amerisourcebergen will likely draw upon its...
- Defense Logistics Agency awarded a $204 firm fixed price delivery order to Amerisourcebergen Drug Corp for 100 mg vials of Leucovorin Calcium. Performance will occur in Conshohocken, Pennsylvania with an expected completion date of October 18, 2023. The award was made off an existing vehicle without a set-aside designation. As a major supplier of pharmaceuticals, medical equipment, and logistical support to the U.S. military and other government agencies, this delivery order will help ensure the...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Leucovorin Calcium 200 mg vials, a medication used in cancer treatment. The contract has a ceiling value of $3,011.81 and a completion date of September 18, 2024. It is a firm-fixed-price contract, and there is no set-aside designation, indicating open competition....
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $1,169.85 contract is for the supply of 500 mg vials of the drug leucovorin calcium. The delivery order is part of a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FQ4R1Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $11,176.92 to AmerisourceBergen Drug Corp for the supply of Leucovorin Calcium 200 mg vials under a firm fixed price contract. The award, issued on September 24, 2025, with an ultimate completion date of September 25, 2025, represents a competitively awarded, non-set-aside procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform this delivery order from its corporate office location. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This prime contract vehicle provides comprehensive pharmaceutical and medical supply support to federal healthcare systems, including the Defense Health Agency, U.S. Coast Guard, and other military medical programs. Leucovorin Calcium is a chemotherapy support medication used to reduce toxicity and enhance efficacy of cancer treatments, supporting critical medical needs across the federal healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.2k | 9/24/25 |